This link is missing in the clinical management of people with DM now that carbohydrate response element-binding protein (ChREBP)—a newly identified lipogenic glucose-sensing transcription factor controlling hepatic lipogenesis—is known to be positively controlled by T3 in mammals [26] through its binding to thyroid receptor β-1. The gene discussed is MLXIPL; the disease is diabetes mellitus.